Improved endurance of patients treated for Hodgkin's ailment has been raised at the cost of late complications, ultimate common of which are subordinate neoplasias including conscience cancers, which make up 6–9% of these neoplasias subsequently treatment for MDH. Survivors of Hodgkin's affliction may have a long life expectancy existing, and it is crucial to develop appropriate plans for estimating the risk recently breast cancer. Young age and radiotherapy are for the most part the most advantageous determinants. In this report, we describe the note of a patient who was treated for Hodgkin's affliction at the age of 17. After 17 years, she was pronounced with triple-negative right feelings cancer and received secondary chemotherapy and radiotherapy in addition to breast-conserving enucleation. We provide an overview of the risk determinants, diagnostic, prognostic, and healing options that are modified for one Hodgkin's disease situation received for these secondary mammary cancers.
Author(s) Details:
Loubna Belhajjam,
Department of Radiotherapy, University Hospital
Center Fes Morocco, Morocco.
Zineb
Alami,
Department
of Radiotherapy, University Hospital Center Fes Morocco, Morocco.
Asmaa Kouadir,
Department of Radiotherapy, University Hospital Center Fes Morocco,
Morocco.
Abderahmane Elmazghi,
Department of Radiotherapy, University Hospital Center Fes Morocco,
Morocco.
Touria
Bouhafa,
Department of Radiotherapy, University Hospital
Center Fes Morocco, Morocco.
Khalid
Hassouni,
Department
of Radiotherapy, University Hospital Center Fes Morocco, Morocco.
Please see the link here: https://stm.bookpi.org/RHDHR-V5/article/view/10113
No comments:
Post a Comment